HOUSTON – Langerhans Cell Histiocytosis (LCH) is a rare disease of white blood cells in which an overabundance of abnormal dendritic cells causes damage to the skin, bone, and other organs, according ...

Histiocytosis is considered a rare disease but doctors at Baylor College of Medicine and Texas Children’s Cancer Center and Hematology Service would argue the accuracy of that label. They are seeing ...

As a result of the rarity of diseases like the histiocytoses, the initial descriptions are usually reports of small numbers of cases in specialist medical journals. Therefore, recruitment of ...

Q: What is Langerhans histiocytosis disease? A: Langerhans cell histiocytosis (LCH), sometimes called histiocytosis X, is a rare cancer (or maybe more accurately a "cancer-like" condition, as some ...

Langerhans cell histiocytosis (LCH) is a rare cancer involving dendritic cells, a type of white blood cell that usually helps fight infections. These cells are especially found in the skin, lymph ...

Robin Bankins says the first time she spoke with MSK’s Dr. Eli Diamond about treating her histiocytosis, she trusted him right away. Based a clinical trial conducted at MSK, the FDA has approved the ...

LCH is a very rare condition that affects both children and adults. Langerhans cells are a type of white blood cell called a histiocyte. They help to fight infection. Langerhans cells are normally ...

08:24, Tue, Mar 28, 2017 Updated: 14:55, Fri, Aug 4, 2017 Almost a year ago I was getting my three-year-old son Sam ready for nursery school one morning when I happened to reach down to ruffle his ...

PHILADELPHIA (WPVI) -- It's a parent's worst nightmare. Allison Gettler was told in June that her 5-year-old son Carter had Langerhans cell histiocytosis, a rare form of pediatric cancer. Carter has ...

The four principal investigators of the award grants from the 2022 grant cycle(From left to right: Dr. Kim Nichols, Dr. Gaurav Goyal, Dr. Scott Canna, Dr. Michael ...

The Key Langerhans Cell Histiocytosis Companies in the market include - Dana-Farber Cancer Institute, GlaxoSmithKline, Shanghai Fosun Pharmaceutical, Shanghai Henlius Biotech, Carl Allen, and others.